Showing results (161-170 of 171) with videos related to
Sort By:
Pageof 18
Clinical & Experimental Metastasis|July 23, 2025
Reconsidering palliative radiotherapy in addition to PD-1 blockade for non-small cell lung cancer: results from the FORCE phase II trial (AIO/YMO-TRK-0415)Farastuk Bozorgmehr, Inn Chung, Jürgen R Fischer, et al.International Journal of Cancer|April 23, 2019
Variant classification in precision oncologyJonas Leichsenring, Peter Horak, Simon Kreutzfeldt, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 12, 2023
Early Detection of Lung Cancer Using Small RNAsTobias Sikosek, Rastislav Horos, Franziska Trudzinski, et al.NPJ Precision Oncology|June 29, 2026
Beyond EML4: efficacy of targeted therapy in lung cancer patients with rare ALK fusions - a real-world retrospective analysisMarie-Elisabeth Leßmann, Felix Carl Saalfeld, Lea Ruge, et al.Pneumologie (Stuttgart, Germany)|October 26, 2023
[Prevention, Diagnosis, Therapy, and Follow-up of Lung Cancer - Interdisciplinary Guideline of the German Respiratory Society and the German Cancer Society - Abridged Version]Wolfgang Schütte, Sylvia Gütz, Wiebke Nehls, et al.Lung Cancer (Amsterdam, Netherlands)|August 18, 2020
GLASS: Global Lorlatinib for ALK(+) and ROS1(+) retrospective Study: real world data of 123 NSCLC patientsNir Peled, Roni Gillis, Saadettin Kilickap, et al.International Journal of Molecular Sciences|April 13, 2024
Mobocertinib in Patients with EGFR Exon 20 Insertion-Positive Non-Small Cell Lung Cancer (MOON): An International Real-World Safety and Efficacy AnalysisOliver Illini, Felix Carl Saalfeld, Petros Christopoulos, et al.JAMA Oncology|July 9, 2026
Consolidative Thoracic Radiotherapy With Atezolizumab Maintenance in Extensive-Stage Small Cell Lung Cancer: The Phase 2 TREASURE Randomized Clinical Trial (AIO-TRK-0320)Farastuk Bozorgmehr, Inn Chung, Rouven Behnisch, et al.Med (New York, N.Y.)|March 19, 2025
Genomic landscape and molecularly informed therapy in thymic carcinoma and other advanced thymic epithelial tumorsLino Möhrmann, Lysann Rostock, Maximilian Werner, et al.Cancer Discovery|April 17, 2023
Comutations and KRASG12C Inhibitor Efficacy in Advanced NSCLCMarcelo V Negrao, Haniel A Araujo, Giuseppe Lamberti, et al.Pageof 18